What sizes are available for NMDAR2C/GRIN2C Rabbit Polyclonal Antibody (Carrier-free)?

NMDAR2C/GRIN2C Rabbit Polyclonal Antibody (Carrier-free) is available in the following size(s): 100 µg.

NMDAR2C/GRIN2C Rabbit Polyclonal Antibody (Carrier-free)

Q: What is the catalog number for NMDAR2C/GRIN2C Rabbit Polyclonal Antibody (Carrier-free)?

The catalog number for NMDAR2C/GRIN2C Rabbit Polyclonal Antibody (Carrier-free) is orb3077700.

Anti-NMDAR2C/GRIN2C Antibody. Tested in WB applications. This antibody reacts with Human, Rat. The brand indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as , ensuring unmatched performance.

Product Specifications

Product Name Alternative

Glutamate ionotropic receptor NMDA type subunit 2C; GluN2C; NMDAR2C; NR2C; GRIN2C

UniProt

Q14957

Reactivity

Human, Rat

Cross Reactivity

No cross-reactivity with other proteins.

Immunogen

E.coli-derived human NMDAR2C recombinant protein (Position: Q43-Q242) . Human NMDAR2C shares 93% and 92.5% amino acid (aa) sequence identity with mouse and rat NMDAR2C, respectively.

Target

Glutamate receptor ionotropic, NMDA 2C

Clonality

Polyclonal

Conjugation

Carrier-free

Field of Research

Neuroscience

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Rat, Human

Form

Lyophilized

Molecular Weight

134 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.